← Back to searchRecruitingRecruiting
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
NCT05919511 · Incyte Corporation
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
Official title
A Prospective, Observational Cohort Study of Participants at Risk for Chronic Graft-Versus-Host Disease in the United States (THRIVE)
About this study
The purpose of this prospective observational study is to collect data from participants who have recently had an allogenic Stem Cell Transplant(alloSCT) and are at risk of Chronic Graft Versus Host Disease(cGVHD)
Eligibility criteria
Inclusion Criteria:
* Age ≥ 18 years inclusive at the time of signing the ICF
* Allogeneic SCT 90 to 180 days prior to enrollment
* Able to comprehend and willing to provide informed consent
* Willing and able to complete participant-assessment questionnaires either alone or with minimal assistance from a caregiver and/or trained site personnel
Exclusion Criteria:
* There are no exclusion criteria for this study
Study design
Enrollment target: 1500 participants
Age groups: adult, older_adult
Timeline
Starts: 2023-08-01
Estimated completion: 2027-10-15
Last updated: 2026-03-24
Interventions
Other: Non-Interventional
Primary outcomes
- • Overall Burden of cGVHD diagnosis and severity (36 months)
Sponsor
Incyte Corporation · industry
Contacts & investigators
ContactIncyte Corporation Call Center (US) · contact · medinfo@incyte.com · 1.855.463.3463
ContactIncyte Corporation Call Center (ex-US) · contact · eumedinfo@incyte.com · +800 00027423
All locations (32)
University of Alabama BirminghamRecruiting
Birmingham, Alabama, United States
Mayo Clinic ArizonaRecruiting
Phoenix, Arizona, United States
City of HopeRecruiting
Duarte, California, United States
USC Norris Comprehensive Cancer CenterRecruiting
Los Angeles, California, United States
University of ColoradoRecruiting
Aurora, Colorado, United States
Mayo Clinic JacksonvilleRecruiting
Jacksonville, Florida, United States
AdventHealth OrlandoRecruiting
Orlando, Florida, United States
Moffit Cancer CenterRecruiting
Orlando, Florida, United States
Emory UniversityRecruiting
Atlanta, Georgia, United States
Georgia Cancer CenterRecruiting
Augusta, Georgia, United States
Northwestern UniversityRecruiting
Chicago, Illinois, United States
Rush University Medical GroupRecruiting
Chicago, Illinois, United States
The University of ChicagoRecruiting
Chicago, Illinois, United States
Loyola University Medical CenterRecruiting
Maywood, Illinois, United States
The University of Kansas Clinical Research CenterRecruiting
Fairway, Kansas, United States
Tulane Cancer CenterCompleted
New Orleans, Louisiana, United States
University of Maryland Medical CenterRecruiting
Baltimore, Maryland, United States
Massachusetts Cancer Research CenterRecruiting
Boston, Massachusetts, United States
Corewell HealthRecruiting
Grand Rapids, Michigan, United States
Mayo Clinic RochesterRecruiting
Rochester, Minnesota, United States
Rutgers Cancer Institute of New JerseyRecruiting
New Brunswick, New Jersey, United States
Memorial Sloan Kettering Cancer CenterRecruiting
New York, New York, United States
University of North Carolina at Chapel HillRecruiting
Chapel Hill, North Carolina, United States
Levine Cancer InstituteRecruiting
Charlotte, North Carolina, United States
The Ohio State UniversityRecruiting
Columbus, Ohio, United States
Oregon Health Sciences UniversityRecruiting
Portland, Oregon, United States
Geisinger Health SystemsRecruiting
Danville, Pennsylvania, United States
Vanderbilt University Medical CenterRecruiting
Nashville, Tennessee, United States
Texas Oncology-Baylor Charles A. Sammons Cancer CenterRecruiting
Dallas, Texas, United States
University of Utah, Huntsman Cancer InstituteRecruiting
Salt Lake City, Utah, United States
Fred Hutchinson Cancer Research CenterRecruiting
Seattle, Washington, United States
Medical College of WisconsinRecruiting
Milwaukee, Wisconsin, United States